Financial Statements · Financial Reporting
Asper Biogene OÜ
Official identifier 14265334Record date 31 Dec 2023
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 1 Jan 2023
- Submitted date
- 27 Jun 2024
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 491,614 |
| Balance sheet | Cash and cash equivalents | 33,748 |
| Balance sheet | Current assets | 196,090 |
| Balance sheet | Current liabilities | 123,518 |
| Balance sheet | Equity | 346,818 |
| Balance sheet | Share capital at nominal value | 2,500 |
| Balance sheet | Non-current assets | 295,524 |
| Balance sheet | Non-current liabilities | 21,278 |
| Balance sheet | Retained earnings (loss) from previous periods | 329,440 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -222,176 |
| Income statement scheme 1 | Labour costs | -247,828 |
| Income statement scheme 1 | Revenue | 825,111 |
| Income statement scheme 1 | Annual period profit / loss | 14,628 |
| Income statement scheme 1 | Operating profit (loss) | 20,191 |
| Income statement scheme 1 | Profit (loss) before income tax | 14,628 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 329,440 |
| Note: Labour costs | Employees | 9 |
| Note: Labour costs | Labour costs | 172,530 |
Linked company
Company: Asper Biogene OÜ